纤维细胞生长因子23和骨质保护素在没有晚期慢性病患者的血管化中的作用
Keisuke Senda1,2, Nami Teraoka1, Kazuma Masuda1
1Department of Cardiology, Aizawa Hospital, Japan.
Internal medicine (Tokyo, Japan)
|December 10, 2025
概括
纤维细胞生长因子23 (FGF-23) 与保留功能的患者的血管化有关. 骨质保护素 (OPG) 在严重的冠状动脉化 (CAC) 方面显示出适度的,未经调整的歧视.
科学领域:
- 心血管医学 心血管医学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 生物标志物研究 生物标志物研究
背景情况:
- 血管化是不良心血管事件的预测因素.
- 化生物标志物在患有功能维护的患者中所起的作用尚不清楚.
- 众所周知,慢性病 (CKD) 会影响血管化.
研究的目的:
- 调查血清FGF-23,OPG和fetuin-A水平与没有晚期CKD的患者的血管化之间的关联.
- 评估这些生物标志物对严重冠状动脉化 (CAC) 的辨别能力.
主要方法:
- 对68名接受冠状动脉计算机断层扫描血管造影和冠状动脉血管造影的患者进行前性研究.
- 测量血清FGF-23,OPG和fetuin-A的水平.
- 对冠状动脉,大动脉,大动脉门和腹部大动脉化的评估.
- 使用斯皮尔曼相关性和ROC分析分析严重的CAC (阿加斯顿≥400).
主要成果:
- 血清FGF-23与CAC相关 (ρ=0.379,p=0.002),大动脉门化,腹部大动脉化和左心室质量指数.
- 骨质保护蛋白 (OPG) 对严重的CAC (AUC=0.69) 显示出适度的,未经调整的歧视,但与年龄没有独立关联.
- 费图因-A和OPG与CAC没有显著的相关性;所有生物标志物都显示出与大动脉结石化存在弱相关性.
结论:
- 在没有晚期CKD的患者中,FGF-23与全身血管化和左心室重塑有关.
- 在这个人群中,OPG为严重的CAC提供了有限的,未调整的歧视性价值.
- 需要进一步的大规模研究来验证这些生物标志物在心血管风险分层中的作用.
相关概念视频
Roles of Electrolytes: Calcium and Phosphate
1.1K
Calcium and phosphate are essential electrolytes in the human body, with calcium being the most abundant mineral. Around 99% of the body's calcium is stored in the skeleton and teeth, forming a crystal lattice of mineral salts in combination with phosphates. Calcium plays crucial roles in various bodily functions such as blood clotting, neurotransmitter release, muscle tone maintenance, and nervous and muscle tissue excitability.
The calcium concentration in blood plasma is primarily...
The calcium concentration in blood plasma is primarily...
1.1K
Role of Vitamins in Maintaining Bone Health
4.9K
The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
4.9K
Osteoclasts in Bone Remodeling
3.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.8K
Skeleton and Calcium Homeostasis
5.7K
Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
5.7K
Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
Chronic Kidney Disease III: Interprofessional Care
316
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
316


